Cetirizine Syrup Dosage
For children aged 6 years and older, cetirizine syrup should be dosed at 5-10 mg once daily, while children aged 6 months to under 6 years should receive 0.25 mg/kg twice daily (or 2.5 mg twice daily for ages 2-6 years, and 2.5 mg once daily for ages 6 months to 2 years). 1
Standard Dosing by Age
Children 6 Years and Older
- Standard dose: 10 mg once daily 1
- Alternative for less severe symptoms: 5 mg once daily 1
- Maximum: Do not exceed 10 mg in 24 hours 1
Children Under 6 Years
Recent pharmacokinetic modeling suggests optimal dosing differs from traditional recommendations 2:
Ages 2-6 years:
Ages 6 months to 2 years:
Ages 6-11 months: 0.25 mg/kg twice daily (mean dose ~4.5 mg/day total) has been documented as safe 3
Important Pharmacokinetic Consideration
Children eliminate cetirizine twice as fast as adults, with a half-life of approximately 5.5 hours versus 10-11 hours in adults 4. This supports twice-daily dosing in younger children for sustained symptom control, though once-daily dosing remains effective for many patients.
Renal Impairment Dosing
The dose must be reduced by half in patients with moderate renal impairment (creatinine clearance 10-80 mL/min), and cetirizine should be avoided entirely in severe renal impairment (creatinine clearance <10 mL/min). 5
Specific Renal Dosing Guidelines
Mild renal impairment (CrCl 50-80 mL/min): Reduce dose by 50% 6
Moderate renal impairment (CrCl 10-50 mL/min): Reduce dose by 50% 5
- Elimination half-life increases to 19-21 hours (versus 7.4 hours in normal function) 6
Severe renal impairment (CrCl <10 mL/min): Avoid cetirizine 5
Hemodialysis patients: 5 mg three times per week during the predialysis period maintains therapeutic levels without accumulation 7
- No supplemental dosing needed between dialysis sessions 7
Elderly Patients
Consult a physician before use in adults 65 years and older 1, as elimination half-life is prolonged and total body clearance is reduced in elderly patients, though this is primarily driven by age-related decline in renal function rather than age itself 6.
Key Safety Considerations
Sedation Risk
Cetirizine may cause sedation at recommended doses (13.7% in patients ≥12 years versus 6.3% with placebo), unlike fexofenadine, loratadine, or desloratadine which do not cause sedation at standard doses 8. Patients should be counseled about this risk, particularly those operating machinery or driving.
Common Pitfalls to Avoid
Do not use standard adult dosing in children under 6 years - they require weight-based or age-specific reduced doses due to faster elimination 4
Do not overlook renal function - failure to reduce doses in renal impairment leads to drug accumulation and increased sedation risk 6
Patients with low body mass may experience elevated drug levels and increased drowsiness even at age-appropriate doses 8
Avoid in severe liver disease due to inappropriate sedating effects 5
Pregnancy and Lactation
While cetirizine is FDA Pregnancy Category B (no evidence of fetal harm), it is best to avoid all antihistamines in pregnancy, especially during the first trimester 5. When antihistamine therapy is necessary, chlorphenamine is often chosen due to its long safety record, though cetirizine and loratadine are considered acceptable alternatives 5.
Efficacy Note
Cetirizine 10 mg demonstrated statistically significant superiority over placebo for seasonal allergic rhinitis symptoms in children ages 6-11 years, with symptom score reductions of -2.1 versus -1.6 (p=0.006) 9. The drug has rapid onset with the shortest time to maximum concentration among second-generation antihistamines 5.